Skip to main content

Vaxcyte, Inc 10-Q for FY2025 Q3

Vaxcyte, Inc. (PCVX)

10-Q 2025-11-04 For: 2025-09-30
View Original
Added on April 07, 2026

About this 10-Q

Vaxcyte, Inc filed this 10-Q on November 4, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$212.83M
compared with a net loss of $103.12M a year earlier
Diluted EPS
-$1.56
compared with -$0.83 a year earlier